Mumbai : Cash And Gold Worth ₹29 Lakh Stolen From Retired GSK Employee's Apartment In Byculla
Shetty, his 54-year-old wife and 28-year-old daughter have lived in their apartment on Matharpacady Road, Mazgaon, Byculla, ...
Merck immune from antitrust claim that it misled FDA about mumps vaccine, court rules
Merck is immune from an antitrust lawsuit accusing it of misleading regulators about the effectiveness of its mumps vaccine ...
Starboard Value takes $1 billion stake in Pfizer: Reports
An activist invester has taken interest in pharma giant Pfizer, which despite becoming a household name during the pandemic ...
One of science’s greatest achievements: how the rapid development of COVID vaccines prepares us for future pandemics
One of the cornerstones of being prepared for the next pandemic is being in the best position possible to design and deploy a ...
Pfizer Wins London Court Battle, GSK's Respiratory Syncytial Virus Vaccine Patents Invalidated
Pfizer Inc. (NYSE:PFE) stock is trading higher with a session volume of 31.16 million as per data from Benzinga Pro. Activist ...
The Pharma Letter6h
ViiV to triple annual supply of long-acting HIV PrEP for low- and middle-income countries
ViiV Healthcare, a GSK-majority-owned HIV specialist, has committed to making at least two million doses of its long-acting ...
GSK rises Monday, outperforms market
Shares of GSK PLC GSK rose 1.40% to £14.80 Monday, on what proved to be an all-around favorable trading session for the stock ...
Low RSV and COVID vaccine usage is in line with investor expectations, but concerning: Jefferies
Low uptake in the RSV and COVID vaccine markets is not surprising, an analyst said, and could mean weak earnings for ...
FiercePharma7h
In long-acting HIV PrEP access showdown with Gilead, GSK moves to triple Apretude supply for certain countries
GSK’s ViiV healthcare unit is countering rival HIV drugmaker Gilead’s recent global access moves with its own pledge to make at least 2 million doses of its long-acting pre-exposure prophylaxis (Pr | ...
U.K. court rules in Pfizer's favor in GSK RSV vaccine dispute: report
Pfizer (PFE) has reportedly succeeded in getting a U.K. court to invalidate two of GSK’s (GSK) patents for its RSV vaccine.
Millions urged to delete data from mail-order DNA test maker
Millions of people who bought DNA tests from genetic testing service 23andme have been urged to delete their personal data ...
pharmaphorum9h
Mpox shows need for new approaches to therapeutic antibody research
Mpox – formerly known as monkeypox – is rapidly spreading in several African countries, prompting the World Health ...